Transcriptional expression of RPMS1 in nasopharyngeal carcinoma and its oncogenic potential

Cell Cycle

Volumn 4, Issue 2, 2005, Pages 303-308

  Li, Ang ^a   Zhang, Xiao Shi ^a   Jiang, Ju Hong ^a   Wang, Hong He ^a   Liu, Xiao Qiong ^a   Pan, Zhi Gang ^a   Zeng, Yi Xin ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

BARTs; Epstein Barr; Nasopharyngeal carcinoma; RPMS1; Virus

Indexed keywords

COMPLEMENTARY DNA; VIRUS PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER PATIENT; CARCINOGENICITY; CELL LINE; CELL STRAIN HEK293; CHINA; CONTROLLED STUDY; COSMID; EPITHELIUM CELL; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; MOUSE; NASOPHARYNX; NASOPHARYNX CARCINOMA; NONHUMAN; OPEN READING FRAME; PERIPHERAL LYMPHOCYTE; PROTEIN EXPRESSION; PROTEIN FAMILY; RNA SPLICING; RNA TRANSCRIPTION; TUMOR BIOPSY; VIRUS INFECTION; VIRUS LATENCY; VIRUS TRANSCRIPTION; XENOGRAFT;

HUMAN HERPESVIRUS 4; MUS MUSCULUS;

EID: 25444435913     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.4.2.1416     Document Type: Article

References (45)

1. Feng BJ, Huang W, Shugart YY, Lee MK, Zhang F, Xia JC, et al. Genome-wide scan for familial nasopharyngeal carcinoma reveals evidence of linkage to chromosome 4. Nat Genet 2002; 31:395-9.
2. Huang DP, Lo KW. Aetiological factors and pathogenesis. In: Van Hasselt GA, Gibb AG, ed. Nasopharyngeal Carcinoma. 2nd ed, Hong Kong: The Chinese University Press 1999;31-60.
3. Abdel-Hamid M, Chen JJ, Constantine N, Massoud M, Raab-Traub N. EBV strain variation: geographical distribution and relation to disease state. Virology 1992; 190:168-75.
4. Zhang XS, Song KH, Mai HQ, Jia WH, Feng BJ, Xia JC, et al. The 30-bp deletion variant: a polymorphism of latent membrane protein 1 prevalent in NPC and non-NPC endemic areas of China. Cancer Lett 2002; 176:65-73.
5. Zheng X, Yuan F, Hu L, Chen F, Klein G, Christensson B. Effect of beta-lymphocyte- and NPC-derived EBV-LMP1 gene expression on in vitro growth and differentiation of human epithelial cells. Int J Cancer 1994; 57:747-53.
6. Scholle F, Bendt KM, Raab-Traub N. Epstein-Barr virus LMP2A transforms epithelial cells, inhibits cell differentiation, and activates Akt. J Virol 2000; 74:10681-9.
7. Wei MX, de Turenne-Tessier M, Decaussin G, Benet G, Ooka T. Establishment of a monkey kidney epithelial cell line with the BARF1 open reading frame from Epstein-Barr virus. Oncogene 1997; 14:3073-81.
8. Komano J, Maruo S, Kurozumi K, Oda T, Takada K. Oncogenic role of Epstein-Barr virus-encoded RNAs in Burkitt's lymphoma cell line Akata. J Virol 1999; 73:9827-31.
9. Brooks LA, Lear AL, Young LS, Rickinson AB. Transcripts from the Epstein-Barr virus BamHI A fragment are detectable in all three forms of latency. J Virol 1993; 67:3182-90.
10. Tao Q, Robertson KD, Manns A, Hildesheim A, Ambinder RF. Epstein-Barr virus (EBV) in endemic Burkitt's lymphoma: molecular analysis of primary tumor tissue. Blood 1998; 91:1373-81.
11. Sugiura M, Imai S, Tokunaga M, Koizumi S, Uchizawa M, Okamoto K, et al. Transcriptional analysis of Epstein-Barr virus gene expression in EBV-positive gastric carcinoma: unique viral latency in the tumor cells. Br J Cancer 1996; 74:625-31.
12. Raab-Traub N, Rajadurai P, Flynn K. Epstein-Barr virus infection in carcinoma of the salivary gland. J Virol 1991; 65:7032-6.
13. Webster-Cyriaque J, Raab-Traub N. Transcription of Epstein-Barr virus latent cycle genes in oral hairy leukoplakia. Virology 1998; 248:53-65.
14. Chiang AK, Tao Q, Srivastava G, Ho FC. Nasal NK- and T-cell lymphomas share the same type of Epstein-Barr virus latency as nasopharyngeal carcinoma and Hodgkin's disease. Int J Cancer 1996; 68:285-90.
15. Deacon EM, Pallesen G, Niedobitek G, Crocker J, Brooks L, Rickinson AB, et al. Epstein-Barr virus and Hodgkin's disease: transcriptional analysis of virus latency in the malignant cells. J Exp Med 1993; 177:339-49.
16. Hitt MM, Allday MJ, Hara T, Karran L, Jones MD, Busson P, et al. EBV gene expression in an NPC-related tumor. EMBO J 1989; 8:2639-51.
17. Gilligan K, Sato H, Rajadurai P, Busson P, Young L, Rickinson A, et al. Novel transcription from the Epstein-Barr virus terminal EcoRI fragment, DIJhet, in a nasopharyngeal carcinoma. J Virol 1990; 64:4948-56.
18. Chen HL, Lung MM, Sham JS, Choy DT, Griffin BE, Ng MH. Transcription of BamHI-A region of the EBV genome in NPC tissues and B cells. Virology 1992; 191:193-201.
19. Gilligan KJ, Rajadurai P, Lin JC, Busson P, Abdel-Hamid M, Prasad U, et al. Expression of the Epstein-Barr virus BamHI A fragment in nasopharyngeal carcinoma: evidence for viral protein expressed in vivo. J Virol 1991; 65:6252-9.
20. Karran L, Gao Y, Smith PR, Griffin BE. Expression of a family of complementary-strand transcripts in Epstein-Barr virus-infected cells. Proc Natl Acad Sci USA 1992; 89:8058-62.
21. Imai S, Nishikawa J, Takada K. Cell-to-cell contact as an efficient mode of Epstein-Barr virus infection of diverse human epithelial cells. J Virol, 1998; 72:4371-8.
22. Sadler RH, Raab-Traub N. Structural analyses of the Epstein-Barr virus BamHI A transcripts. J Virol 1995; 69:1132-41.
23. Kienzle N, Sculley TB, Poulsen L, Buck M, Cross S, Raab-Traub N, et al. Identification of a cytotoxic T-lymphocyte response to the novel BARF0 protein of Epstein-Barr virus: a critical role for antigen expression. J Virol 1998; 72:6614-20.
24. Fries KL, Sculley TB, Webster-Cyriaque J, Rajadurai P, Sadler RH, Raab-Traub N. Identification of a novel protein encoded by the BamHI A region of the Epstein-Barr virus. J Virol 1997; 71:2765-71.
25. Kienzle N, Buck M, Greco S, Krauer K, Sculley TB. Epstein-Barr virus-encoded RK-BARF0 protein expression. J Virol 1999; 73:8902-6.
26. van Beek J, Brink AA, Vervoort MB, van Zijp MJ, Meijer CJ, van den Brule AJ, et al. In vivo transcription of the Epstein-Barr virus (EBV) BamHI-A region without associated in vivo BARF0 protein expression in multiple EBV-associated disorders. J Gen Virol 2003; 84:2647-59.
27. Smith PR, de Jesus O, Turner D, Hollyoake M, Karstegl CE, Griffin BE, et al. Structure and coding content of CST (BARTs) family RNAs of Epstein-Barr virus. J Virol 2000; 74:3082-92.
28. Zhang J, Chen H, Weinmaster G, Hayward SD. Epstein-Barr Virus BamHI-A Rightward Transcript-Encoded RPMS Protein Interacts with the CBF1-Associated Corepressor CIR To Negatively Regulate the Activity of EBNA2 and NotchIC. J Virol 2001; 75:2946-56.
29. Griffin BE, Karran L. Immortalisation of monkey epithelial cells by specific fragment of Epstein-Barr virus DNA. Nature 1984; 309:79-82.
30. Izumi KM. Identification of EBV transforming genes by recombinant EBV technology. Semin Cancer Biol 2001; 11:407-414.
31. Decaussin G, Sbih-Lammali F, de Turenne-Tessier M, Bouguermouh A, Ooka T. Expression of BARF1 gene encoded by Epstein-Barr virus in nasopharyngeal carcinoma biopsies. Cancer Res 2000; 60:5584-8.
32. Lam N, Sugden B. CD40 and its viral mimic, LMP1: similar means to different ends. Cell Signal 2003; 15:9-16.
33. Strobl LJ, Hofelmayr H, Marschall G, Brielmeier M, Bornkamm GW, Zimber-Strobl U. Activated Notch1 modulates gene expression in B cells similarly to Epstein-Barr viral nuclear antigen 2. J Virol 2000; 74:1727-35.
34. Artavanis-Tsakonas S, Rand MD, Lake RJ. Notch signaling: cell fate control and signal integration in development. Science 1999; 284:770-6.
35. Miele L, Osborne B. Arbiter of differentiation and death: Notch signaling meets apoptosis. J Cell Physiol 1999; 181:393-409.
36. Grego-Bessa J, Diez J, Timmerman L, De La Pompa JL. Notch and epithelial-mesenchyme transition in development and tumor progression: another turn of the screw. Cell Cycle 2004; 3:718-21.
37. Rangarajan A, Talora C, Okuyama R, Nicolas M, Mammucari C, Oh H, et al. Notch signaling is a direct determinant of keratinocyte growth arrest and entry into differentiation. EMBO J 2001; 20:3427-36.
38. Allenspach EJ, Maillard I, Aster JC, Pear WS. Notch signaling in cancer. Cancer Biol Ther 2002; 1:466-76.
39. Daniel B, Rangarajan A, Mukherjee G, Vallikad E, Krishna S. The link between integration and expression of human papillomavirus type 16 genomes and cellular changes in the evolution of cervical intraepithelial neoplastic lesions. J Gen Virol 1997;78:1095-101.
40. Suzuki T, Aoki D, Susumu N, Udagawa Y, Nozawa S. Imbalanced expression of TAN-1 and human Notch4 in endometrial cancers. Int J Oncol 2000; 17:1131-9.
41. Leethanakul C, Patel V, Gillespie J, Pallente M, Ensley JF, Koontongkaew S, et al. Distinct pattern of expression of differentiation and growth-related genes in squamous cell carcinomas of the head and neck revealed by the use of laser capture microdissection and cDNA arrays. Oncogene 2000; 19:3220-4.
42. Imatani A, Callahan R. Identification of a novel NOTCH-4/INT-3 RNA species encoding an activated gene product in certain human tumor cell lines. Oncogene 2000;19:223-31.
43. Weijzen S, Zlobin A, Braid M, Miele L, Kast WM. HPV16 E6 and E7 oncoproteins regulate Notch-1 expression and cooperate to induce transformation. J Cell Physiol 2003; 194:356-62.
44. Lathion S, Schaper J, Beard P, Raj K. Notch1 can contribute to viral-induced transformation of primary human keratinocytes. Cancer Res 2003; 63:8687-94.
45. Dang TP, Eichenberger S, Gonzalez A, Olson S, Carbone DP. Constitutive activation of Notch3 inhibits terminal epithelial differentiation in lungs of transgenic mice. Oncogene 2003; 22:1988-97.